16.6.2016 Víctor Cervera-Carrascón, an EU funded student working at TILT wins poster award for his work with anti-PD1 checkpoint inhibition enhanced by TILT technology at Finnish Cancer Institute Symposium.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA